Yposkesi is one of the largest GMP viral vector CDMO’s in Europe. We offer customers access to our high producing cell lines and platform processes for both adherent and suspension to develop and manufacture AAV and LVV. We have 4 independent manufacturing suites with batch sizes up to 600L as well as two sterile fill/finish lines. In addition, we will have 1000L capacity starting in Q1 2022. We are also building a commercial facility (2023) that will have two manufacturing lines. Each line will have capacity for up to 2,000L and will be able to produce a total of 40 batches per year. In additional we offer full analytical and process development services.